about
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Th...
Read More
3.20
0.02
(0.63%)
246.5K
XNAS Volume
XNAS 04 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Agenus Inc is on 11 Mar 2026 for the purpose of Agenus Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Agenus Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..